New Step by Step Map For Imipenem
MI-CP151 was a stage 1b randomised, double-blind, placebo controlled, dose-escalation, multicentre analyze To judge multiple intravenous doses of sifalimumab, in Grownup clients with dermatomyositis or polymyositis (NCT00533091). Principal demo goals were being to evaluate the protection and tolerability of sifalimumab in dermatomyositis or polymyo